ID   Hs 68
AC   CVCL_0839
SY   HS 68; HS-68; Hs68
DR   BTO; BTO:0002260
DR   CLO; CLO_0004041
DR   CLO; CLO_0004255
DR   CLDB; cl1719
DR   ATCC; CRL-1635
DR   BCRC; 60038
DR   BioSample; SAMN01821561
DR   BioSample; SAMN01821730
DR   BioSample; SAMN03471410
DR   CCRID; 4201HUM-CCTCC00614
DR   CCTCC; GDC0403
DR   ChEMBL-Cells; CHEMBL3307408
DR   ChEMBL-Targets; CHEMBL614578
DR   ECACC; 89051701
DR   GEO; GSE39177
DR   JCRB; IFO50350
DR   PubChem_Cell_line; CVCL_0839
DR   Wikidata; Q54895867
RX   PubMed=23311377;
WW   https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-306.html
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Senescence: Senesces after 42 PDL (ATCC=CRL-1635).
CC   Doubling time: ~1.2 days (Note=Lot 01242005), ~2 days (Note=Lot 01222018) (JCRB=IFO50350).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
ST   Source(s): ATCC; JCRB
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C84611; Canavan disease
DI   ORDO; Orphanet_141; Canavan disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 21
//
RX   PubMed=23311377; DOI=10.3109/02656736.2012.753163;
RA   Tabuchi Y., Furusawa Y., Kariya A., Wada S., Ohtsuka K., Kondo T.;
RT   "Common gene expression patterns responsive to mild temperature
RT   hyperthermia in normal human fibroblastic cells.";
RL   Int. J. Hyperthermia 29:38-50(2013).
//